Question 1

What is ARS Pharmaceuticals, Inc.'s total operating expenses?

Accepted Answer

ARS Pharmaceuticals, Inc. (SPRY) reported total operating expenses of $82.83M in Q1 2026.

Question 2

How has ARS Pharmaceuticals, Inc.'s total operating expenses changed year-over-year?

Accepted Answer

ARS Pharmaceuticals, Inc.'s total operating expenses increased by 83.4% year-over-year, from $45.15M to $82.83M.

Question 3

What is the long-term trend for ARS Pharmaceuticals, Inc.'s total operating expenses?

Accepted Answer

Over 3 years (2022 to 2025), ARS Pharmaceuticals, Inc.'s total operating expenses has grown at a 92.7% compound annual growth rate (CAGR), from $36.83M to $263.73M.

Question 4

What does total operating expenses mean?

Accepted Answer

The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.

Line item	Three Months Ended March 31, 2026	Three Months Ended March 31, 2025
Cost of goods sold (including related party amounts of $1,233 and $488, respectively)	6,286	1,094
Research and development (including related party amounts of $667 and $666, respectively)	4,336	2,952
Selling, general and administrative (including related party amounts of $135 and $124, respectively)	72,204	41,104
Total operating expenses	82,826	45,150
Loss from operations	(60,145)	(37,177)
Other income (expense), net:
Interest income	1,968	3,237
Interest expense (including related party amounts of $122 and $0, respectively)	(2,441)	—

Total Operating Expenses at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about ARS Pharmaceuticals, Inc.'s total operating expenses.

ARS Pharmaceuticals, Inc. SPRY Total Operating Expenses